Should sponsors and dsmbs share interim results across trials?

Seema Kirti Shah; Liza Dawson; Dennis O. Dixon; Reidar K. Lie

doi:10.1097/QAI.0b013e318236eca3

Should sponsors and dsmbs share interim results across trials?

Seema Kirti Shah^*, Liza Dawson, Dennis O. Dixon, Reidar K. Lie

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	433-435
Number of pages	3
Journal	Journal of Acquired Immune Deficiency Syndromes
Volume	58
Issue number	5
DOIs	https://doi.org/10.1097/QAI.0b013e318236eca3
State	Published - Dec 15 2011

ASJC Scopus subject areas

Infectious Diseases
Pharmacology (medical)

Access to Document

10.1097/QAI.0b013e318236eca3

Cite this

@article{3155e2e082bd49a9910dcd15d1fdc1ad,

title = "Should sponsors and dsmbs share interim results across trials?",

author = "Shah, {Seema Kirti} and Liza Dawson and Dixon, {Dennis O.} and Lie, {Reidar K.}",

year = "2011",

month = dec,

day = "15",

doi = "10.1097/QAI.0b013e318236eca3",

language = "English (US)",

volume = "58",

pages = "433--435",

journal = "Journal of Acquired Immune Deficiency Syndromes",

issn = "1525-4135",